Purchase Order FA301019PA004
- Not listed
- This is a firm fixed-price purchase order awarded by the Air Education and Training Command (AETC), a defense agency, to Genomic Health, Inc. for pathology testing services. The contract has a ceiling value of $3,453.96 and a completion date of October 12, 2018. Genomic Health, Inc. is a subsidiary of Exact Sciences Corporation that specializes in providing advanced genetic testing services, particularly for cancer screening, treatment selection, and disease monitoring. The company has a...
- This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
- This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...
- The Department of the Air Force Air Combat Command awarded a $124,588.79 firm fixed price delivery order to Genomic Health, Inc. for Oncotype DX cancer testing services during the ordering period from March 2023 through March 2024. Genomic Health is a subsidiary of Exact Sciences Corporation which will perform the testing through its laboratory services division Exact Sciences Laboratories. The delivery order was awarded without a set-aside designation to support the Air Force's cancer screening...
- This federal contract award is for the provision of 2 Oncotype DX Pathology Tests by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract was awarded by the Air Education and Training Command, a defense agency, and has a ceiling value of $6,907.92. It is a firm fixed-price delivery order contract under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does not have a set-aside designation. Genomic Health, Inc. is the...
- This is a Definitive Contract awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services. The $642,816.16 firm fixed-price contract covers the provision of these specialized genomic diagnostic services to various military and veterans' healthcare facilities, including Travis Air Force Base, from January 1, 2020 to March 31, 2025. Genomic Health, Inc. has significant federal Indefinite Delivery Vehicle (IDV)...
- This award is for a purchase order of $78,364.30 to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide breast cancer testing services to the Defense Health Agency. The contract has a firm fixed price pricing type and a completion date of September 30, 2016. Genomic Health is a for-profit organization that specializes in providing genomic cancer testing services to the federal government, including the Department of Veterans Affairs, Department of Defense, Air Force,...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The contract has a ceiling value of $30,416.18 and a period of performance ending on March 31, 2017. Genomic Health, Inc. is a for-profit organization that specializes in providing advanced genetic testing services, particularly the Oncotype DX portfolio of genomic assays, to federal...
- This is a firm fixed-price BPA call order awarded by the Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of express cancer testing services, specifically Oncotype DX assays, to support the VA's healthcare programs. Genomic Health, as a provider of genomic-based cancer diagnostic tests, has received numerous prime and subcontractor awards from various federal agencies, including the...
- This is a delivery order awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of Oncotype cancer testing services to the Defense Health Agency (DHA). The contract has a ceiling value of $124,588.79 and a period of performance from March 16, 2025, to March 15, 2026, with the testing to be performed at Nellis Air Force Base in Nevada. The contract is a firm fixed-price type and does not have a set-aside designation. Genomic Health, Inc. is a for-profit...
This is a $6,907.92 firm fixed-price purchase order awarded by the U.S. Air Education and Training Command to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract is for the provision of Oncotype Pathology Test services, which are advanced genetic testing services used to support cancer screening, treatment selection, and disease monitoring. Genomic Health, Inc. is an experienced federal contractor, having previously secured multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs, Defense Health Agency, and Air Force Air Combat Command, valued at up to $5,000,000 and $996,710, for the delivery of Oncotype cancer testing services across various military and veterans' healthcare networks. This latest award does not have a set-aside designation. The contract has a period of performance through February 13, 2019.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 2/11/19 |